HomeInsightsStock Comparison

Piramal Pharma Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Piramal Pharma Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Last Updated on: Jun 29, 2025

Key Highlights

  • The Latest Trading Price of Piramal Pharma Ltd is ₹ 202.9 as of 27 Jun 15:30.
  • The P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 0 on March 2022 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from 0 on March 2023 to 0 on March 2022 . This represents a CAGR of 0.0% over 4 years.
  • The Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Sun Pharma Advanced Research Company Ltd changed from ₹ 5823 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 4 years.
  • The revenue of Piramal Pharma Ltd for the Mar '25 is ₹ 2812 crore as compare to the Dec '24 revenue of ₹ 2233 crore. This represent the growth of 25.92% The revenue of Sun Pharma Advanced Research Company Ltd for the Mar '25 is ₹ 27.19 crore as compare to the Dec '24 revenue of ₹ 15.1 crore. This represent the growth of 80.07%.
  • The ebitda of Piramal Pharma Ltd for the Mar '25 is ₹ 619.24 crore as compare to the Dec '24 ebitda of ₹ 366.92 crore. This represent the growth of 68.77% The ebitda of Sun Pharma Advanced Research Company Ltd for the Mar '25 is ₹ -53.18 crore as compare to the Dec '24 ebitda of ₹ -73.5 crore. This represent the decline of -27.65%.
  • The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 153.5 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.35 crore to ₹ -59.77 crore over 8 quarters. This represents a CAGR of -20.83% .
  • The Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 3.72 % on March 2024 . This represents a CAGR of -40.95% over 3 yearsThe Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

About Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
  • The Company works on innovation and new product development for global markets.
  • They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Ltd was incorporated on March 1, 2006 as an innovative and development company.
  • They commenced operations on March 22, 2006.
  • As per Scheme of Arrangement, all assets and liabilities of the Innovative Research & Development business including Novel Drug Delivery System (NDDS) division of Sun Pharmaceuticals Industries' Research & Development undertaking stands transferred and vested in the Company with effect from Appointed date on February 28, 2007.

Piramal Pharma Ltd News Hub

News

Piramal Pharma to conduct AGM

Piramal Pharma announced that the 5th Annual General Meeting(AGM) of the company will be h...

Read more

14 Jun 2025 14:54

News

Piramal Pharma's Aurora unit completes USFDA inspection

Piramal Pharma announced that the US FDA conducted a general GMP (Good Manufacturing Pract...

Read more

02 Jun 2025 16:21

News

Piramal Pharma's Canada facility gets zero USFDA observation

According to a regulatory filing, the inspection was carried out from 26 May 2025 to 30 Ma...

Read more

02 Jun 2025 11:16

News

Piramal Pharma allots 35 lakh equity shares under ESOP

Piramal Pharma has allotted 35 lakh equity shares under ESOP on 21 May 2025. Consequent to...

Read more

21 May 2025 15:37

News

Board of Piramal Pharma recommends final dividend

Piramal Pharma announced that the Board of Directors of the Company at its meeting held on...

Read more

15 May 2025 10:18

News

Piramal Pharma's Turbhe facility successfully completes USFDA inspection

Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR...

Read more

12 May 2025 12:47

Sun Pharma Advanced Research Company Ltd News Hub

News

Sun Pharma Advanced Research Company Ltd leads losers in 'A' group

Aditya Birla Fashion & Retail Ltd, Fusion Finance Ltd Partly Paidup, Alivus Life Sciences ...

Read more

04 Jun 2025 15:00

News

SPARC tanks after psoriasis, eczema drug flunks Phase 2 trials

In a regulatory filing, SPARC said that its partner, Sun Pharmaceutical Industries (SPIL),...

Read more

04 Jun 2025 15:02

News

Sun Pharma Advanced Research Company to table results

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

13 May 2025 15:59

News

Sun Pharma Advanced Research Company submits IND application to USFDA

Sun Pharma Advanced Research Company announced submission of an Investigational New Drug (...

Read more

31 Mar 2025 10:19

News

SPARC submits application for its ADC to US FDA to conduct global phase-1 study

The IND application supports the next phase of development of SBO-154 which has completed ...

Read more

31 Mar 2025 13:58

News

Volumes jump at Sun Pharma Advanced Research Company Ltd counter

Kalpataru Projects International Ltd, Inox Wind Ltd, Data Patterns (India) Ltd, Triveni Tu...

Read more

07 Mar 2025 14:30

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharma Advanced Research Company Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharma Advanced Research Company Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Piramal Pharma Ltd and Sun Pharma Advanced Research Company Ltd

Which company has a larger market capitalization, Piramal Pharma Ltd or Sun Pharma Advanced Research Company Ltd?

Market cap of Piramal Pharma Ltd is 26,970 Cr while Market cap of Sun Pharma Advanced Research Company Ltd is 5,244 Cr

What are the key factors driving the stock performance of Piramal Pharma Ltd and Sun Pharma Advanced Research Company Ltd?

The stock performance of Piramal Pharma Ltd and Sun Pharma Advanced Research Company Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Piramal Pharma Ltd and Sun Pharma Advanced Research Company Ltd?

As of June 29, 2025, the Piramal Pharma Ltd stock price is INR ₹202.9. On the other hand, Sun Pharma Advanced Research Company Ltd stock price is INR ₹161.6.

How do dividend payouts of Piramal Pharma Ltd and Sun Pharma Advanced Research Company Ltd compare?

To compare the dividend payouts of Piramal Pharma Ltd and Sun Pharma Advanced Research Company Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions